Gilead Sciences is based out of Foster City. Gilead Sciences is a biopharmaceutical company. Co.'s product portfolio includes Truvada��, Atripla��, Viread�� and Emtriva�� for the treatment of human immunodeficiency virus infection; Hepsera�� and Viread for the treatment of hepatitis B; AmBisome�� for the treatment of fungal infections; Letairis�� for the treatment of pulmonary arterial hypertension; Ranexa�� for the treatment of angina; Vistide�� for the treatment of cytomegalovirus retinitis; and Cayston�� for cystic fibrosis patients with Pseudomonas aeruginosa. Co. owns or have rights to a range of trademarks, copyrights and trade names, such as, among others, GILEAD��, GILEAD SCIENCES��, TRUVADA��, VIREAD��, and HEPSERA��.Whalewisdom has at least 9 13D filings, 26 13G filings, and 672 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
GILEAD SCIENCES, INC.333 LAKESIDE DR
FOSTER CITY CA 94404
Business Phone: 6505743000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
| Stock | Sector | Shares Held | Market Value | Rank | Source | Source Date |
|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | HEALTH CARE | 31,532,782 | 482,451,565 | 1 | 13D | 2024-01-31 |
| Arcellx Inc | HEALTH CARE | 6,720,813 | 373,005,122 | 2 | 13G | 2023-12-28 |
| Kyverna Therapeutics Inc. | 4,126,129 | 123,495,041 | 3 | 13G | 2024-02-20 | |
| Hookipa Pharma Inc | HEALTH CARE | 18,759,475 | 15,195,175 | 4 | 13G | 2023-12-22 |
| AlloVir, Inc. | HEALTH CARE | 16,635,296 | 11,312,001 | 5 | 13G | 2024-02-13 |
| Assembly Biosciences Inc | HEALTH CARE | 13,073,668 | 10,716,124 | 6 | 13D | 2023-10-25 |
| Ikena Oncology Inc | HEALTH CARE | 2,931,477 | 5,775,010 | 7 | 13G | 2023-10-19 |
| Xilio Therapeutics Inc | HEALTH CARE | 7,345,483 | 4,693,764 | 8 | 13G | 2024-04-05 |